相似文献
1
Severe interferon associated retinopathy.
Br J Ophthalmol. 2003 Feb;87(2):247-8. doi: 10.1136/bjo.87.2.247.
2
Interferon-associated retinopathy in a diabetic patient.
Eye (Lond). 1999 Jun;13 ( Pt 3a):376-7. doi: 10.1038/eye.1999.97.
3
Symptomatic interferon retinopathy successfully treated by hypertension management.
Br J Ophthalmol. 2007 Sep;91(9):1250-1. doi: 10.1136/bjo.2006.112532.
4
Interferon-associated retinopathy in a young, insulin-dependent diabetic patient.
Retina. 2000;20(4):413-5. doi: 10.1097/00006982-200004000-00023.
5
Optical Coherence Tomography Angiography in the Multimodal Imaging Evaluation of Interferon-Associated Retinopathy: A Case Report.
Ophthalmic Surg Lasers Imaging Retina. 2017 Jun 1;48(6):498-504. doi: 10.3928/23258160-20170601-09.
6
Is screening for interferon retinopathy in hepatitis C justified?
Br J Ophthalmol. 2004 Dec;88(12):1518-20. doi: 10.1136/bjo.2004.043968.
7
[Bilateral retinal microangiopathy in interferon therapy of malignant melanoma of the skin].
Klin Monbl Augenheilkd. 2000 Nov;217(5):308-11. doi: 10.1055/s-2000-10374.
8
Photosensitive seizures associated with interferon alfa-2a.
Ann Pharmacother. 1999 Jan;33(1):113-4. doi: 10.1345/aph.18183.
9
[Reversible Perimacular Retinopathy by Long-Time Interferon alpha Therapy].
Klin Monbl Augenheilkd. 2004 Jan;221(1):63-6. doi: 10.1055/s-2003-812642.
10
Literature systematic review on the ophthalmological side effects of interferons.
Arq Bras Oftalmol. 2011 Jul-Aug;74(4):306-10. doi: 10.1590/s0004-27492011000400017.
引用本文的文献
1
Role of interferons in diabetic retinopathy.
World J Diabetes. 2021 Jul 15;12(7):939-953. doi: 10.4239/wjd.v12.i7.939.
2
A Drop in Hemoglobin as an Association with Pegylated Interferon Retinopathy: A Novel Pathophysiology.
J Curr Ophthalmol. 2020 Apr 30;32(2):195-198. doi: 10.4103/JOCO.JOCO_103_20. eCollection 2020 Apr-Jun.
3
Ocular side effects of antirheumatic medications: a qualitative review.
BMJ Open Ophthalmol. 2020 Jan 7;5(1):e000331. doi: 10.1136/bmjophth-2019-000331. eCollection 2020.
4
Interferon-associated retinopathy risk in patients with diabetes and hypertensive hepatitis C.
World J Gastroenterol. 2014 Jun 21;20(23):7505-13. doi: 10.3748/wjg.v20.i23.7505.
5
Pegylated interferon-associated severe retinopathy in a patient with chronic hepatitis.
Korean J Ophthalmol. 2012 Apr;26(2):147-50. doi: 10.3341/kjo.2012.26.2.147. Epub 2012 Mar 22.
6
Interferon-alpha-associated presumed ocular sarcoidosis.
Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):675-80. doi: 10.1007/s00417-008-1002-5. Epub 2008 Nov 26.
7
Is screening for interferon retinopathy in hepatitis C justified?
Br J Ophthalmol. 2004 Dec;88(12):1518-20. doi: 10.1136/bjo.2004.043968.
本文引用的文献
1
Interferon-associated retinopathy and cystoid macular edema.
Arch Ophthalmol. 2001 Jul;119(7):1077-9.
2
Retinopathy associated with high-dose interferon alfa-2b therapy.
Am J Ophthalmol. 2001 Jun;131(6):782-7. doi: 10.1016/s0002-9394(01)00836-4.
3
Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration.
Br J Ophthalmol. 1999 Aug;83(8):923-8. doi: 10.1136/bjo.83.8.923.
4
Interferon associated retinopathy.
Br J Ophthalmol. 1998 Mar;82(3):323-5. doi: 10.1136/bjo.82.3.323.
5
Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol. 1997 Jul;115(7):865-72. doi: 10.1001/archopht.1997.01100160035005.
6
[Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis].
Nippon Ganka Gakkai Zasshi. 1996 Jan;100(1):69-76.
7
Interferon alfa induces leukocyte capillary trapping in rat retinal microcirculation.
Arch Ophthalmol. 1996 Jun;114(6):726-30. doi: 10.1001/archopht.1996.01100130718014.
8
Interferon-associated retinopathy.
Arch Ophthalmol. 1993 Mar;111(3):350-6. doi: 10.1001/archopht.1993.01090030068041.
Zotero 插件